Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Ticklel1ston Dec 02, 2021 8:43pm
92 Views
Post# 34192898

RE:RE:RE:RE:RE:RE:December report

RE:RE:RE:RE:RE:RE:December report BIOran. So, China is not at stage 3 yet. When they get to 3 they pay another 1.5 Million? It's taken 7 years to get to stage 2 and let's say they make stage 3 in 2022 baring any chinese new year delays or other excuses management can come up with. So, logic says that at every 2 stages completed they pay 1.5. Sound about right? & years and the get about 30% of the 9.5 million.

 Fruck, it's been 7 years and they haven't complete the second yet. At 7 years for every 3 million payout is going to take another 14 years or so to get the 9.5!!

This does not look like it will be in my life time. Heck, the whole management team could be gone.

Howhee...do you care to comment on my math? Like maybe you can spin the remaining  payout in maybe 10 years?
<< Previous
Bullboard Posts
Next >>